Choroidal Thickness in Ocular Sarcoidosis during Quiescent Phase Using Enhanced Depth Imaging Optical Coherence Tomography
| dc.contributor.author | Gungor, Sirel Gur | |
| dc.contributor.author | Akkoyun, Imren | |
| dc.contributor.author | Reyhan, Nihan Haberal | |
| dc.contributor.author | Yesilirmak, Nilufer | |
| dc.contributor.author | Yilmaz, Gursel | |
| dc.contributor.orcID | https://orcid.org/0000-0001-6178-8362 | en_US |
| dc.contributor.orcID | https://orcid.org/0000-0002-2860-7424 | en_US |
| dc.contributor.orcID | https://orcid.org/0000-0001-9852-9911 | en_US |
| dc.contributor.orcID | https://orcid.org/0000-0002-8632-2873 | en_US |
| dc.contributor.orcID | https://orcid.org/0000-0002-2589-7294 | en_US |
| dc.contributor.pubmedID | 24912003 | en_US |
| dc.contributor.researcherID | AAD-5967-2021 | en_US |
| dc.contributor.researcherID | AAK-7713-2021 | en_US |
| dc.contributor.researcherID | AAK-4587-2021 | en_US |
| dc.contributor.researcherID | AAD-7299-2020 | en_US |
| dc.contributor.researcherID | AAK-6987-2021 | en_US |
| dc.date.accessioned | 2024-01-29T12:50:39Z | |
| dc.date.available | 2024-01-29T12:50:39Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Purpose: To evaluate the choroidal thickness in patients with ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography (EDI-OCT) and comparing it with normal subjects. Method: Eighteen eyes of 9 patients with ocular sarcoidosis (8 women, 1 man, mean age: 59.12 +/- 18.49 years) were enrolled in this study. Their subfoveal choroidal thickness was measured using EDI-OCT in the quiescent phase of uveitis, and compared with the age-, sex-, and spherical equivalent-matched normal subjects (6 women, 3 men, mean age: 59.6 +/- 14.22 years). Results: The mean subfoveal choroidal thickness was 281.76 +/- 88.1 mm in patients with sarcoidosis and 342.32 +/- 71.02 mm in controls. Significant differences were found at points between nasal 1500 mm and temporal 1000 mm to the fovea between patients and control group (p = 0.002, at fovea). Conclusions: Patients with ocular sarcoidosis had thinner choroids in the quiescent phases when compared to normal subjects. | en_US |
| dc.identifier.endpage | 293 | en_US |
| dc.identifier.issn | 0927-3948 | en_US |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.scopus | 2-s2.0-84904277576 | en_US |
| dc.identifier.startpage | 287 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11727/11355 | |
| dc.identifier.volume | 22 | en_US |
| dc.identifier.wos | 000339806300007 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.3109/09273948.2014.920034 | en_US |
| dc.relation.journal | OCULAR IMMUNOLOGY AND INFLAMMATION | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Choroidal thickness | en_US |
| dc.subject | enhanced depth imaging optical coherence tomography | en_US |
| dc.subject | quiescent phase | en_US |
| dc.subject | sarcoidosis | en_US |
| dc.subject | uveitis | en_US |
| dc.title | Choroidal Thickness in Ocular Sarcoidosis during Quiescent Phase Using Enhanced Depth Imaging Optical Coherence Tomography | en_US |
| dc.type | article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: